Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.51
-0.21 (-1.43%)
Apr 25, 2025, 10:39 AM EDT - Market open
Arcutis Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Cash & Equivalents | 71.34 | 88.4 | 53.64 | 96.45 | 65.08 | Upgrade
|
| Short-Term Investments | 156.62 | 183.46 | 355.95 | 290.61 | 219.36 | Upgrade
|
| Cash & Short-Term Investments | 227.96 | 271.86 | 409.59 | 387.06 | 284.44 | Upgrade
|
| Cash Growth | -16.15% | -33.63% | 5.82% | 36.08% | 180.89% | Upgrade
|
| Accounts Receivable | 73.07 | 25.81 | 8.46 | - | - | Upgrade
|
| Other Receivables | - | - | - | - | 0.51 | Upgrade
|
| Receivables | 73.07 | 25.81 | 8.46 | - | 0.51 | Upgrade
|
| Inventory | 14.53 | 13.13 | 7.51 | - | - | Upgrade
|
| Prepaid Expenses | 12.29 | 10.1 | 7.39 | 14.17 | 6.33 | Upgrade
|
| Restricted Cash | 0.62 | 0.93 | 1.23 | 1.54 | 1.54 | Upgrade
|
| Other Current Assets | 7.37 | 8.61 | 3.23 | - | - | Upgrade
|
| Total Current Assets | 335.82 | 330.43 | 437.41 | 402.77 | 292.83 | Upgrade
|
| Property, Plant & Equipment | 2.99 | 3.9 | 4.6 | 5.3 | 5.37 | Upgrade
|
| Other Intangible Assets | 9.48 | 6.44 | 7.19 | - | - | Upgrade
|
| Other Long-Term Assets | 0.6 | 0.6 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Total Assets | 348.89 | 341.37 | 449.27 | 408.15 | 298.27 | Upgrade
|
| Accounts Payable | 14.22 | 11.99 | 8.83 | 7.35 | 7.14 | Upgrade
|
| Accrued Expenses | 65.97 | 33.94 | 28.32 | 25.54 | 15.29 | Upgrade
|
| Current Portion of Leases | 0.82 | 0.74 | 0.66 | 0.43 | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.18 | Upgrade
|
| Total Current Liabilities | 81.01 | 46.67 | 37.81 | 33.33 | 22.6 | Upgrade
|
| Long-Term Debt | 107.2 | 201.8 | 197.77 | 72.35 | - | Upgrade
|
| Long-Term Leases | 2.56 | 3.38 | 4.12 | 4.77 | 4.96 | Upgrade
|
| Other Long-Term Liabilities | 0.57 | 0.85 | - | 0.03 | 0.08 | Upgrade
|
| Total Liabilities | 191.35 | 252.7 | 239.69 | 110.48 | 27.65 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,279 | 1,071 | 930.43 | 706.23 | 472.57 | Upgrade
|
| Retained Earnings | -1,122 | -981.9 | -719.76 | -408.31 | -201.95 | Upgrade
|
| Comprehensive Income & Other | -0.01 | 0 | -1.09 | -0.26 | -0 | Upgrade
|
| Total Common Equity | 157.54 | 88.67 | 209.58 | 297.68 | 270.62 | Upgrade
|
| Shareholders' Equity | 157.54 | 88.67 | 209.58 | 297.68 | 270.62 | Upgrade
|
| Total Liabilities & Equity | 348.89 | 341.37 | 449.27 | 408.15 | 298.27 | Upgrade
|
| Total Debt | 110.59 | 205.92 | 202.54 | 77.56 | 4.96 | Upgrade
|
| Net Cash (Debt) | 117.37 | 65.95 | 207.05 | 309.5 | 279.48 | Upgrade
|
| Net Cash Growth | 77.98% | -68.15% | -33.10% | 10.74% | 176.83% | Upgrade
|
| Net Cash Per Share | 0.97 | 0.95 | 3.76 | 6.26 | 7.84 | Upgrade
|
| Filing Date Shares Outstanding | 118.64 | 96.81 | 61.08 | 50.38 | 50.08 | Upgrade
|
| Total Common Shares Outstanding | 117.85 | 96.79 | 61.04 | 50.26 | 43.34 | Upgrade
|
| Working Capital | 254.81 | 283.76 | 399.6 | 369.45 | 270.22 | Upgrade
|
| Book Value Per Share | 1.34 | 0.92 | 3.43 | 5.92 | 6.24 | Upgrade
|
| Tangible Book Value | 148.06 | 82.23 | 202.39 | 297.68 | 270.62 | Upgrade
|
| Tangible Book Value Per Share | 1.26 | 0.85 | 3.32 | 5.92 | 6.24 | Upgrade
|
| Machinery | 1.93 | 1.79 | 1.36 | 1.12 | 0.52 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.3 | Upgrade
|
| Leasehold Improvements | 1.57 | 1.57 | 1.57 | 1.57 | 1.28 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.